Concepedia

Publication | Closed Access

Inhibition of BET Bromodomain Targets Genetically Diverse Glioblastoma

DOI

290

Citations

37

References

2013

Year

Zhixiang Cheng, Yuanying Gong, Yufang Ma, Kaihua Lu, Xiang Lu, Larry A. Pierce, Reid C. Thompson, Susanne Müller, Stefan Knapp, Jialiang Wang
Clinical Cancer Research

Abstract

Our results suggest potentially broad therapeutic use of BET bromodomain inhibitors for treating genetically diverse glioblastoma tumors.

References

YearCitations

Page 1